Stanniocalcin 2 (STC2): a Universal Tumour Biomarker and a Potential Therapeutical Target

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2022 May 3

PMID 35501821

Authors

Shuo Qie

Nianli Sang

Affiliations

Soon will be listed here.

Abstract

Stanniocalcin 2 (STC2) is a glycoprotein which is expressed in a broad spectrum of tumour cells and tumour tissues derived from human breast, colorectum, stomach, esophagus, prostate, kidney, liver, bone, ovary, lung and so forth. The expression of STC2 is regulated at both transcriptional and post-transcriptional levels; particularly, STC2 is significantly stimulated under various stress conditions like ER stress, hypoxia and nutrient deprivation. Biologically, STC2 facilitates cells dealing with stress conditions and prevents apoptosis. Importantly, STC2 also promotes the development of acquired resistance to chemo- and radio- therapies. In addition, multiple groups have reported that STC2 overexpression promotes cell proliferation, migration and immune response. Therefore, the overexpression of STC2 is positively correlated with tumour growth, invasion, metastasis and patients' prognosis, highlighting its potential as a biomarker and a therapeutic target. This review focuses on discussing the regulation, biological functions and clinical importance of STC2 in human cancers. Future perspectives in this field will also be discussed.

Citing Articles

Predictive Value of Gene Expression in Chemotherapy Response in Breast Cancer.

Munoz J, Lampe-Huenul N Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006048 PMC: 11859796. DOI: 10.3390/ph18020235.

Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes.

Zhang C, Zhang X, Dai S, Yang W Front Genet. 2025; 15:1522484.

PMID: 39882072 PMC: 11774838. DOI: 10.3389/fgene.2024.1522484.

A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression.

Mohd Faizal N, Shai S, Savaliya B, Karen-Ng L, Kumari R, Kumar R Biomedicines. 2025; 13(1).

PMID: 39857718 PMC: 11759772. DOI: 10.3390/biomedicines13010134.

Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma.

Wu H, Cao S, Xu Z, Wang T, Ji G, Wang K BMC Cancer. 2025; 25(1):131.

PMID: 39849389 PMC: 11756198. DOI: 10.1186/s12885-025-13433-4.

CH25H Promotes Autophagy and Regulates the Malignant Progression of Laryngeal Squamous Cell Carcinoma Through the PI3K-AKT Pathway.

Xiang Z, Yu S, Xu Y, Xiong H, Hu D, Li Q Cancer Med. 2024; 13(20):e70312.

PMID: 39428922 PMC: 11491687. DOI: 10.1002/cam4.70312.

References

Klopfleisch R, Gruber A . Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. J Comp Pathol. 2009; 141(2-3):113-20. DOI: 10.1016/j.jcpa.2008.09.010. View

Sun G, Liu M, Han H . Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in.... J Cell Physiol. 2019; 234(10):17824-17838. DOI: 10.1002/jcp.28409. View

Chen L, He X, Yi S, Liu G, Liu Y, Ling Y . Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Biomed Res Int. 2021; 2021:8824195. PMC: 7889344. DOI: 10.1155/2021/8824195. View

Roche F, Pietila I, Kaito H, Sjostrom E, Sobotzki N, Noguer O . Leukocyte Differentiation by Histidine-Rich Glycoprotein/Stanniocalcin-2 Complex Regulates Murine Glioma Growth through Modulation of Antitumor Immunity. Mol Cancer Ther. 2018; 17(9):1961-1972. DOI: 10.1158/1535-7163.MCT-18-0097. View

Yoshiko Y, Aubin J . Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides. 2004; 25(10):1663-9. DOI: 10.1016/j.peptides.2004.04.015. View

Dong M, Miao L, Zhang F, Li S, Han J, Yu R . Nuclear factor-κB p65 regulates glutaminase 1 expression in human hepatocellular carcinoma. Onco Targets Ther. 2018; 11:3721-3729. PMC: 6029591. DOI: 10.2147/OTT.S167408. View

Fang Z, Tian Z, Luo K, Song H, Yi J . Clinical significance of stanniocalcin expression in tissue and serum of gastric cancer patients. Chin J Cancer Res. 2014; 26(5):602-10. PMC: 4220260. DOI: 10.3978/j.issn.1000-9604.2014.10.08. View

Marouli E, Graff M, Medina-Gomez C, Lo K, Wood A, Kjaer T . Rare and low-frequency coding variants alter human adult height. Nature. 2017; 542(7640):186-190. PMC: 5302847. DOI: 10.1038/nature21039. View

Singh N, Ramnarine V, Song J, Pandey R, Padi S, Nouri M . The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nat Commun. 2021; 12(1):7349. PMC: 8692330. DOI: 10.1038/s41467-021-26901-9. View

10.

Wagner G, Hampong M, Park C, Copp D . Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius. Gen Comp Endocrinol. 1986; 63(3):481-91. DOI: 10.1016/0016-6480(86)90149-8. View

11.

Liu Y, Tsai M, Wu S, Chang T, Tsai T, Gow C . Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer. Int J Cancer. 2019; 145(6):1609-1624. DOI: 10.1002/ijc.32487. View

12.

Volland S, Kugler W, Schweigerer L, Wilting J, Becker J . Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma. Int J Cancer. 2009; 125(9):2049-57. DOI: 10.1002/ijc.24564. View

13.

Raulic S, Ramos-Valdes Y, DiMattia G . Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro. J Endocrinol. 2008; 197(3):517-29. DOI: 10.1677/JOE-08-0043. View

14.

Kita Y, Mimori K, Iwatsuki M, Yokobori T, Ieta K, Tanaka F . STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma. Ann Surg Oncol. 2010; 18(1):261-72. DOI: 10.1245/s10434-010-1271-1. View

15.

Qie S, Chu C, Li W, Wang C, Sang N . ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation. J Cell Biochem. 2013; 115(3):498-509. PMC: 4518873. DOI: 10.1002/jcb.24684. View

16.

Chen S, Sang N . Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells. J Cell Biochem. 2015; 117(2):267-78. PMC: 4715696. DOI: 10.1002/jcb.25283. View

17.

Zhang C, Guan Z, Peng J . [The correlation between stanniocalcin 2 expression and prognosis in laryngeal squamous cell cancer]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015; 29(2):102-7. View

18.

Goulet A, Watts G, Lord J, Nelson M . Profiling of selenomethionine responsive genes in colon cancer by microarray analysis. Cancer Biol Ther. 2007; 6(4):494-503. DOI: 10.4161/cbt.6.4.3813. View

19.

Qie S, Yoshida A, Parnham S, Oleinik N, Beeson G, Beeson C . Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nat Commun. 2019; 10(1):1296. PMC: 6428878. DOI: 10.1038/s41467-019-09179-w. View

20.

Zhang L, Wei Z, Wang Y, Xu F, Cheng Z . Long noncoding RNA ROR1-AS1 enhances STC2-mediated cell growth and autophagy in cervical cancer through miR-670-3p. J Recept Signal Transduct Res. 2020; 41(6):582-592. DOI: 10.1080/10799893.2020.1836495. View